About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Department of Nuclear Medicine
›
top-articles
Department of Nuclear Medicine
146
(top 1%)
papers
9.1K
(top 1%)
citations
47
(top 1%)
h
-index
94
(top 1%)
g
-index
150
all documents
9.7K
doc citations
1.4K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Evaluation of Hybrid
68
Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Journal of Nuclear Medicine
2015
907
2
Diagnostic Efficacy of
68
Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Journal of Urology
2016
659
3
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study
European Journal of Nuclear Medicine and Molecular Imaging
2003
510
4
Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
European Urology
2016
456
5
68
Ga- and
177
Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Journal of Nuclear Medicine
2015
432
6
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy
International Journal of Radiation Oncology Biology Physics
2005
351
7
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging
Journal of Nuclear Medicine
1999
331
8
Effect of
APOE
genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Neurology
2009
235
9
68
Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning
Journal of Nuclear Medicine
2018
226
10
Value of
68
Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy
Journal of Nuclear Medicine
2016
213
11
99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer
European Urology
2019
195
12
Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
European Urology
2015
192
13
Preclinical Evaluation and First Patient Application of
99m
Tc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
Journal of Nuclear Medicine
2017
170
14
PSMA Ligands for PET Imaging of Prostate Cancer
Journal of Nuclear Medicine
2017
165
15
Initial Characterization of an
18
F-Labeled Myocardial Perfusion Tracer
Journal of Nuclear Medicine
2008
145
16
Radiation Dosimetry for
177
Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
Journal of Nuclear Medicine
2017
144
17
18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression
Molecular Imaging and Biology
2010
131
18
Assessment of Local Brain Activation
Advances in Experimental Medicine and Biology
1997
127
19
Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors
Journal of Experimental Medicine
2018
121
20
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study
Lancet Oncology, The
2021
120
21
68
Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective Study
Journal of Nuclear Medicine
2017
111
22
68
Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging
Journal of Nuclear Medicine
2018
106
23
Self-gated MRI motion modeling for respiratory motion compensation in integrated PET/MRI
Medical Image Analysis
2015
103
24
Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study
European Journal of Nuclear Medicine and Molecular Imaging
2015
100
25
11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy
International Journal of Radiation Oncology Biology Physics
2006
97
26
Personalized Radiotherapy Design for Glioblastoma: Integrating Mathematical Tumor Models, Multimodal Scans, and Bayesian Inference
IEEE Transactions on Medical Imaging
2019
96
27
Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer
68
Ga-Pentixafor for PET
Journal of Nuclear Medicine
2017
94
28
Value of
111
In‐prostate‐specific membrane antigen (
PSMA
)‐radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow‐up
BJU International
2017
88
29
Effect of 11C-Methionine-Positron Emission Tomography on Gross Tumor Volume Delineation in Stereotactic Radiotherapy of Skull Base Meningiomas
International Journal of Radiation Oncology Biology Physics
2008
85
30
Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET
European Journal of Nuclear Medicine and Molecular Imaging
2004
84
31
Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer
Journal of Nuclear Medicine
2019
76
32
Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy
European Urology
2012
75
33
Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells
European Journal of Nuclear Medicine and Molecular Imaging
2006
74
34
Resting-State Networks as Simultaneously Measured with Functional MRI and PET
Journal of Nuclear Medicine
2017
71
35
Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction
Journal of Nuclear Medicine
2005
71
36
18
F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
Journal of Nuclear Medicine
2020
67
37
Detection Efficacy of Hybrid
68
Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
Journal of Nuclear Medicine
2017
66
38
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer
Nature Reviews Urology
2019
62
39
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
European Journal of Nuclear Medicine and Molecular Imaging
2023
62
40
A New
18
F-Labeled Myocardial PET Tracer: Myocardial Uptake After Permanent and Transient Coronary Occlusion in Rats
Journal of Nuclear Medicine
2008
60
41
Evaluation of a Novel
18
F-Labeled Positron-Emission Tomography Perfusion Tracer for the Assessment of Myocardial Infarct Size in Rats
Circulation: Cardiovascular Imaging
2009
58
42
Analgesia by electrostimulation of the trigeminal ganglion in patients with trigeminopathic pain: a PET activation study
Pain
2003
56
43
Magnetic resonance imaging of myocardial injury and ventricular torsion after marathon running
Clinical Science
2011
55
44
Evaluation of Feasibility and Image Quality of 68Ga-DOTATOC Positron Emission Tomography/Magnetic Resonance in Comparison With Positron Emission Tomography/Computed Tomography in Patients With Neuroendocrine Tumors
Investigative Radiology
2013
55
45
One-Stop-Shop Whole-Body
68
Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer
Journal of Nuclear Medicine
2018
55
46
The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for
177
Lu-Labeled PSMA Peptides
Journal of Nuclear Medicine
2018
54
47
Disruption of the PRKCD–FBXO25–HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis
Nature Medicine
2014
50
48
Targets for Therapy of Bladder Cancer
Seminars in Nuclear Medicine
2020
49
49
Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity
Contraception
1997
48
50
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0
European Journal of Nuclear Medicine and Molecular Imaging
2022
48
site/software ©
exaly
; All materials licenced under
CC by-SA
.